Development and Characterization of COVID-19 vaccine candidate
The goal of this study will be to characterize a SARS-CoV2 antigen and the formulated drug product that will contain SARS-CoV2 antigen and a squalene-based adjuvant under tight timeline to release the material for COVID-19 vaccine clinical trials.
Intern:
Gabriella Gerzon
Faculty Supervisor:
Yi Sheng;Paola Battiston
Province:
Ontario
University:
Partner:
Partner University:
Discipline:
Program:
